Anthem Biosciences Share Price Target 2025: Technical Outlook
Anthem Biosciences Ltd., a high-growth contract research and manufacturing (CRDMO) firm, made waves with its successful IPO in July. Investors are closely monitoring technical indicators to gauge its 2025 potential.
2. Market Snapshot (Today’s Data)
-
Current Price: ₹744.85 as of August 12, 2025
-
52-Week Range: ₹701.75 – ₹801.85
-
Market Cap: ₹41.71KCr
-
Recent Financials: FY25 reported revenue of ₹1,844.6 crore (+30% YoY) and net profit of ₹451.3 crore (+23% YoY)
3. Technical Analysis Snapshot
-
Daily Indicator: Technical rating based on moving averages shows a Buy signal
-
Analyst Research: IPO-related reports highlight premium valuation due to growth and profitability
4. 2025 Price Target Scenarios
Sources forecast diverse 2025 ranges:
-
SharePrice-Target.com estimates a broad ₹583–₹1,224 range (midpoint ~₹900)
-
TheTaxHeaven.com projects a narrower ₹720–₹770
| Scenario | Target Range | Potential Trigger |
|---|---|---|
| Bullish | ₹900–₹1,000 | Sustained buying and breakout above ₹800 (52-week high) |
| Base | ₹720–₹770 | Sideways consolidation within current bounds |
| Bearish | ₹700–₹720 | Pullback below ₹701 support level |
5. Key Drivers & Risks
-
Growth Catalysts: Robust FY25 results, global client base, integrated R&D/manufacturing model
-
Risks: Elevated valuation multiples, market volatility, and competition in the CRDMO space
Anthem Biosciences currently trades near the lower half of its 52-week range with bullish technical indicators. A sustained push above the ₹800 mark could set the stage for a move toward ₹900–₹1,000 by 2025. Alternatively, failure to hold below ₹700 may challenge upside scenarios. Close attention to price action and volume is essential.
